Updated:
StatLab Medical Products
StatLab Medical Products, led by CEO Sue Chang, manufactures histology and cytology consumables for 5,000+ labs from McKinney, Texas.
StatLab Medical Products
Founded in 1988, StatLab Medical Products manufactures and distributes histology, cytology, and immunohistochemistry consumables for clinical and research laboratories. Sue Chang serves as CEO, guiding a strategy centered on acquiring complementary manufacturers and distributors to expand the firm's product catalog and customer base. The company's catalog includes microscope slides, paraffin waxes, reagents, and cassette printers, positioning StatLab as a goods provider rather than an investment entity allocating to external funds. The firm operates through operational acquisitions rather than passive investment commitments. Its manufacturing facilities produce laboratory supplies, and its distribution network reaches clinical pathology labs, research hospitals, and reference laboratories. While StatLab does not disclose an AUM, its physical footprint and acquisition volume — including the purchase of Arizona-based Cancer Diagnostics in 2019 — reflect deployment into hard assets and operational logistics. The geographic footprint extends across the United States, with sales to diagnostic labs in North America and select international markets. StatLab expanded its histology consumables line through the 2019 acquisition of Cancer Diagnostics, adding stains and control slides to its portfolio. The firm operates additional manufacturing and distribution sites beyond its McKinney headquarters. There is no disclosed timeline for external fundraising, no co-investor club, and no reported philanthropic foundation tied to the operating company. As of the most recent public activity, the firm has not disclosed specific ownership structure details for its acquired brands. A structural differentiator for StatLab is its status as a product-line consolidator in a niche scientific supply chain. Unlike a family office deploying capital into third-party funds, StatLab acquires, operates, and integrates small manufacturers to serve a distinct end market. This operational holding-company posture — combining manufacturing capacity with direct distribution — separates it from financial allocators common in the family office universe.
General information
Firm type
Asset Manager
Year founded
1988
AUM
Undisclosed
Location
Region
North America
Country
United States
City
McKinney
Corporate office
McKinney, TX, United States
Principals
Sue Chang
CEO
Sector focus
Frequently asked questions
Does StatLab Medical Products operate as a family office or a manufacturing company?
StatLab operates as a manufacturer and distributor of medical laboratory supplies, not as a family office allocating capital to external funds. The firm acquires complementary histology and cytology product lines and integrates them into its own manufacturing and distribution network, making it an operational holding company rather than an investment vehicle.
What types of products does StatLab manufacture and distribute?
StatLab's catalog includes microscope slides, tissue embedding media such as paraffin waxes, immunohistochemistry reagents, stains, and cassette printers used in histology and cytology workflows. These consumables support clinical pathology labs, research hospitals, and reference laboratories.
How does StatLab grow its business?
The firm grows through acquisition of smaller manufacturers and distributors in the diagnostics consumables space. A recent example is the 2019 purchase of Cancer Diagnostics, which added proprietary stains and control slides to StatLab's existing product portfolio. The acquired companies are integrated into StatLab's operational footprint rather than held as passive investments.
Who runs investment decisions at StatLab Medical Products?
CEO Sue Chang leads the firm's overall strategy, including acquisition decisions. Because StatLab is an operating company and not a fund manager or family office, acquisitions are conducted as corporate transactions to expand manufacturing capability, geographic reach, or product lines, rather than as portfolio investments requiring an investment committee.
Is StatLab backed by private equity or is it independently owned?
Public record does not confirm the firm's ownership structure. StatLab does not disclose whether it is privately held by a family or founder, backed by a private equity sponsor, or structured as an independent operating company. No regulatory filings specifying beneficial ownership are readily available.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: